Improving Vision Despite Macular Degeneration
Innovative contact lens with decentered pinhole for age related degeneration (AMD) patients
Patients with Dry or Wet Age-related Macular Degeneration (AMD) face significant vision problems. This progressive eye condition affects the macula, the central part of the retina responsible for sharp, central vision. In dry AMD, the most common form, the macula gradually thins and breaks down over time, leading to a loss of central vision. This can result in difficulties with activities like reading, recognizing faces, and driving. Wet AMD, although less common, involves the growth of abnormal blood vessels beneath the macula, which can leak fluid or blood, causing rapid and severe vision loss. Both forms of AMD can largely impair a person’s ability to perform daily tasks and negatively impact their overall quality of life, highlighting the urgent need for effective treatments and interventions to manage and mitigate the associated vision problems.
Inventors
Gonen Omer
Dr. Ori Mahler, Kaplan Medical Center
Contact info
Sari Prutchi Sagiv PhD. Director of Pharma and Diagnostics
For further information please contact:
sari@mor-research.comWe have successfully developed an innovative contact lens designed to address these challenges faced by AMD patients and restore vision for those who have lost central vision.
It's important to note that typically, in AMD peripheral vision is preserved, which means patients may still have some functional vision outside the central area. This novel lens allows AMD patients to bypass the damaged central area in the retina, maximizing their visual capability by utilizing their remaining peripheral sensors, and thus compensating for the loss of central vision.
The development of a contact lens specifically designed to assist patients with AMD in restoring their vision represents a significant market opportunity, as this prevalent eye condition affecting millions of individuals worldwide leads to substantial vision loss.
Beyond addressing AMD, this innovative method holds great potential for treating other ocular conditions such as corneal scars, keratoconus, and various other types of injuries.
We have developed a lens trial set and are planning to start a clinical study in AMD patients